Impairment or total absence of corneal sensation are the hallmarks of neurotrophic keratopathy, an uncommon degenerative disease.
Quality-of-life issues have stepped into the spotlight for glaucoma, and ophthalmologists are learning how to incorporate new insights and tools into their clinical practice.
The silent nature of glaucoma makes the disease especially challenging, which is why Prevent Blindness is collaborating with other leading eye care groups in declaring January as National Gl
The glaucoma medication market is thriving today with newer medications that are increasingly efficacious with a new mechanism of action.
Optical coherence tomography detects abnormalities and progressive thinning of the retinal nerve fiber layer better than measurement of the visual fields.
This article was reviewed by David R. Chow, MD, FRCSC.
This article was reviewed by Claude F. Burgoyne, MD
This article was reviewed by Jullia A. Rosdahl, MD, PhD
The intraocular pressure-lowering drugs netarsudil ophthalmic solution 0.02% and latanoprost 0.005% administered separately and then compared with the fixed-combination formulation are similar regarding their effect on the corneal endothelium.